Literature DB >> 13627824

Clinical and experimental studies on serum pyridine nucleotide-linked dehydrogenases in liver damage.

S K WOLFSON, J A SPENCER, R L STERKEI, H G WILLIAMS-ASHMAN.   

Abstract

Entities:  

Keywords:  DEHYDROGENASES/in blood; LIVER DISEASES/blood in

Mesh:

Substances:

Year:  1958        PMID: 13627824     DOI: 10.1111/j.1749-6632.1958.tb36872.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  7 in total

1.  Studies on isocitric and lactic dehydrogenases in experimental myocardial infarction.

Authors:  P E STRANDJORD; K E THOMAS; L P WHITE
Journal:  J Clin Invest       Date:  1959-12       Impact factor: 14.808

2.  [Comparative studies of various TPN dependent dehydrogenases and other serum enzymes in patients with progressive muscular dystrophy].

Authors:  G Giusti; A Ascione; L Cacciatore
Journal:  Klin Wochenschr       Date:  1967-03-15

3.  [Enzyme distribution pattern in the serum of patients with psoriasis vulgaris I].

Authors:  H Holzmann; B Morsches
Journal:  Arch Klin Exp Dermatol       Date:  1968-05-09

4.  BIOCHEMICAL LABORATORY TESTS IN VIRAL HEPATITIS AND OTHER HEPATIC DISEASES. EVALUATION AND FOLLOW-UP.

Authors:  F DERITIS; G GIUSTI; F PICCININO; L CACCIATORE
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

5.  Purification and comparative properties of isoenzymes of nicotinamide-adenine dinucleotide phosphate-isocitrate dehydrogenase from rat heart and liver.

Authors:  M Islam; J L Bell; D N Baron
Journal:  Biochem J       Date:  1972-10       Impact factor: 3.857

Review 6.  RELATIONSHIPS OF ENZYMOLOGY TO CANCER: A REVIEW.

Authors:  W R DOUGLAS
Journal:  Br J Cancer       Date:  1963-09       Impact factor: 7.640

7.  Hypercitricemia in human cancer. Factors concerned in pathogenesis and treatment.

Authors:  H M LEMON; J H MUELLER; J M LOONEY; W H CHASEN; M KELMAN
Journal:  Br J Cancer       Date:  1960-06       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.